Prime Capital Investment Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Buy
2,989
+116
+4% +$30.8K 0.01% 447
2026
Q1
$315K Buy
2,873
+53
+2% +$7.55K ﹤0.01% 817
2025
Q4
$469K Buy
2,820
+11
+0.4% +$1.84K 0.01% 679
2025
Q3
$550K Sell
2,809
-909
-24% -$149K 0.01% 608
2025
Q2
$336K Buy
+3,718
New +$294K ﹤0.01% 733

Other funds holding ALAB

Prime Capital Investment Advisors's ALAB Position: Q2 2026 in Review

Prime Capital Investment Advisors increased its Astera Labs (ALAB) stake by 4% in Q2 2026, buying an estimated $30.8K and bringing the position to 2,989 shares worth $1.44M. The position accounts for 0.01% of the portfolio, ranked #447.

Prime Capital Investment Advisors first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 770 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Prime Capital Investment Advisors held 2,989 shares of Astera Labs worth $1.44M as of Q2 2026.
  • Prime Capital Investment Advisors bought 116 Astera Labs shares in Q2 2026, an estimated $30.8K.
  • Astera Labs made up 0.01% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #447 holding.
  • Prime Capital Investment Advisors first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 770 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.